FDA Alerts
Modified Monitoring for Rx Clozapine
The U.S. Food and Drug Administration (FDA) is making changes to the requirements for monitoring, prescribing, dispensing, and receiving the schizophrenia medicine clozapine, to address continuing safety concerns and current knowledge about a serious blood condition called severe neutropenia.
New Schizophrenia Rx Approved
On July 10, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD).
First Generic Abilify Approved
The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole).
FDA Warns of Rare but Serious Skin Reactions from Ziprasidone
FDA is warning that the antipsychotic drug ziprasidone (marketed under the brand name, Geodon, and its generics) is associated with a rare but serious skin reaction that can progress to affect other parts of the body.
FDA Investigating Two Deaths Following Injection of Zyprexa Relprevv
The US Food and Drug Administration (FDA) is investigating two unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa Relprevv (olanzapine pamoate).
FDA Approves First Generic Olanzapine
The U.S. Food and Drug Administration today approved the first generic versions of Zyprexa ( olanzapine tablets) and Zyprexa Zydus ( olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder.
FDA Drug Safety Communication: Saphris
The U.S. Food and Drug Administration (FDA) is warning the public that serious allergic reactions have been reported with the use of the antipsychotic medication Saphris ( asenapine maleate ).
Risperdal (risperidone) and Risperidone Recall
Ortho-McNeil-Janssen Pharmaceuticals notified healthcare professionals and the public of a recall of specific lots of Risperdal ( risperidone ) 3mg tablets and risperidone 2mg tablets.
Medication Errors Resulting From Name Confusion
The U.S. Food and Drug Administration (FDA) is alerting the public to medication error reports in which patients were given risperidone ( Risperdal ) instead of ropinirole ( Requip ) and vice versa. In some cases, patients who took the wrong medication needed to be hospitalized.
Motherhood is About to Make You a Little Crazier
FDA notified healthcare professionals that the Pregnancy section of drug labels for the entire class of antipsychotic drugs has been updated.